Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage

Journal of Neurosurgical Anesthesiology

Volumn 20, Issue 3, 2008, Pages 193-198

  Muroi, Carl ^a   Frei, Karl ^a   El Beltagy, Mohamed ^a   Cesnulis, Evaldas ^a   Yonekawa, Yasuhiro ^a   Keller, Emanuela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cytokine; Hypothermia; IL 6; Inflammation; Subarachnoid hemorrhage

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; THIOPENTAL; TUMOR NECROSIS FACTOR ALPHA; BARBITURIC ACID DERIVATIVE;

ADULT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; BARBITURATE COMA; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HUMAN; INDUCED HYPOTHERMIA; LEUKOCYTE COUNT; LOADING DRUG DOSE; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBARACHNOID HEMORRHAGE; AGED; BLOOD; CRYOANESTHESIA; HOSPITALIZATION; INFLAMMATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; URINE;

ADULT; AGED; BARBITURATES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49649111178     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31817996bf     Document Type: Article

References (40)

1. Kikuchi T, Okuda Y, Kaito N, et al. Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res. 1995;17:106-108.
2. Takizawa T, Tada T, Kitazawa K, et al. Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subar-achnoid hemorrhage. Neurol Res. 2001;23:724-730.
3. Gaetani P, Tartara F, Pignatti P, et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res. 1998;20: 337-342.
4. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123-133.
5. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70:534-537.
6. Sercombe R, Tran Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002; 88:227-249.
7. Provencio JJ, Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol. 2005;25:435-444.
8. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16:774-780.
9. Polin RS, Bavbek M, Shaffrey ME, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg. 1998; 89:559-567.
10. Handa Y, Kaneko M, Tsuchida A, et al. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien). 1995; 132:92-97.
11. Sasaki T, Kasuya H, Onda H, et al. Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2004;35:1466-1470.
12. Osuka K, Watanabe Y, Yamauchi K, et al. Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage. Brain Res. 2006;1072:1-7.
13. Yatsushige H, Yamaguchi M, Zhou C, et al. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke. 2005;36:1538-1543.
14. Zhou ML, Wu W, Ding YS, et al. Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res. 2007;1173:110-116.
15. Deng H, Han HS, Cheng D, et al. Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation. Stroke. 2003;34:2495-2501.
16. Yanagawa Y, Kawakami M, Okada Y. Moderate hypothermia alters interleukin-6 and interleukin-1alpha reactions in ischemic brain in mice. Resuscitation. 2002;53:93-99.
17. Wang GJ, Deng HY, Maier CM, et al. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience. 2002; 114:1081-1090.
18. Sutcliffe IT, Smith HA, Stanimirovic D, et al. Effects of moderate hypothermia on IL-1 beta-induced leukocyte rolling and adhesion in pial microcirculation of mice and on proinflammatory gene expression in human cerebral endothelial cells. J Cereb Blood Flow Metab. 2001;21:1310-1319.
19. Goss JR, Styren SD, Miller PD, et al. Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma. 1995; 12:159-167.
20. Aibiki M, Maekawa S, Ogura S, et al. Effect of moderate hypothermia on systemic and internal jugular plasma IL-6 levels after traumatic brain injury in humans. J Neurotrauma. 1999; 16:225-232.
21. Abe R, Hirasawa H, Oda S. Influence of brain hypothermia on blood interleukin-6 levels on postresucitated patients after cardiac arrest. In: Hayashi N, Bullock R, Dietrich DW, et al, eds. Hypothermia for Acute Brain Damage: Pathomechanism and Practical Aspects. Tokyo: Springer Verlag; 2004:315-319.
22. Loop T, Liu Z, Humar M, et al. Thiopental inhibits the activation of nuclear factor kappaB. Anesthesiology. 2002;96:1202-1213.
23. Gasser S, Khan N, Yonekawa Y, et al. Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications. J Neurosurg Anesthesiol. 2003;15:240-248.
24. Lerch C, Yonekawa Y, Muroi C, et al. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5:85-92.
25. Keller E, Krayenbuehl N, Bjeljac M, et al. Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir (Wien). 2005;94(suppl):65-73.
26. Mathiesen T, Andersson B, Loftenius A, et al. Increased interleukin6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg. 1993;78:562-567.
27. Neil-Dwyer G, Cruickshank J. The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. Brain. 1974; 97:79-86.
28. Parkinson D, Stephensen S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol. 1984;21:132-134.
29. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006;66:232-234.
30. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002;22:1399-1419.
31. Naidech AM, Drescher J, Tamul P, et al. Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77:1340-1344.
32. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557-563.
33. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
34. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care; AANS/CNS. Guidelines for the management of severe traumatic brain injury. III. Prophylactic hypothermia. J Neurotrauma. 2007;24(suppl 1):S21-S25.
35. Thome C, Schubert GA, Schilling L. Hypothermia as a neuroprotective strategy in subarachnoid hemorrhage: a pathophysiological review focusing on the acute phase. Neurol Res. 2005;27:229-237.
36. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 1999;10: 119-130.
37. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med. 2002;8:1363-1368.
38. Nawashiro H, Tasaki K, Ruetzler CA, et al. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 1997;17:483-490.
39. Castillo J, Moro MA, Blanco M, et al. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol. 2003;54:811-819.
40. Schmidt O, Morganti-Kossmann MC, Heyde CE, et al. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. J Neuroinflammation. 2004;1:13..